(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from Bloomberg ...
(Bloomberg) -- Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal full-year outlook and the third delay to its quarterly ...
When the companies first unveiled their takeover plans, Novo Holdings and Catalent said ... Bloomberg reported back in February of 2023 that life sciences conglomerate Danaher had expressed an ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
, opens new tab beat quarterly profit and sales expectations on Tuesday, driven by strength in its diagnostics and bioprocessing businesses, sending shares of the life sciences firm up more than 7 ...
WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Tuesday reported first-quarter profit of $1.09 billion. The Washington-based company said it had net income of $1.45 per share.